Related Experiment Video
Updated: Jul 17, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Insights
A new pentavalent rotavirus vaccine (RotaTeq) is now available for infants in the United States. This vaccine is recommended for routine immunization at 2, 4, and 6 months of age.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Rotavirus is a leading cause of severe diarrheal disease in infants globally.
- The development of effective rotavirus vaccines is crucial for public health.
- Pentavalent rotavirus vaccines offer broad protection against common serotypes.
Purpose of the Study:
- To announce the licensing and recommended use of a novel bovine-based pentavalent rotavirus vaccine.
- To provide guidelines for the optimal administration schedule of the vaccine.
- To inform healthcare providers about vaccine coadministration and contraindications.
Main Methods:
- Licensure by the US Food and Drug Administration (FDA).
- Recommendations from the American Academy of Pediatrics (AAP).
- Oral administration of the vaccine.
Main Results:
- The pentavalent rotavirus vaccine (RotaTeq) was licensed on February 3, 2006.
- Recommended schedule: 3 doses at 2, 4, and 6 months of age.
- Vaccine can be given with other routine childhood immunizations.
Conclusions:
- The introduction of RotaTeq provides a new tool for preventing rotavirus gastroenteritis in infants.
- Adherence to the recommended age and interval is essential for vaccine efficacy.
- Healthcare providers must screen for contraindications, such as severe allergic reactions.
Abstract:
On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.
Related Concept Videos
Respiratory Syncytial Virus Disease
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Poliomyelitis
Drug Dosing: Infants and Children
Bacterial Gastroenteritis
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
